{"id":52,"date":"2012-12-13T16:02:26","date_gmt":"2012-12-13T14:02:26","guid":{"rendered":"http:\/\/www.mk-stracon.com\/en\/?page_id=52"},"modified":"2018-07-03T13:51:37","modified_gmt":"2018-07-03T11:51:37","slug":"career-history","status":"publish","type":"page","link":"https:\/\/www.mk-stracon.com\/?page_id=52","title":{"rendered":"Career history"},"content":{"rendered":"<h1>As of Sep. 2013: Lecturer\u00a0in Personalized Medicine<\/h1>\n<p><strong>Eidgen\u00f6ssische Technische Hochschule, Zurich <\/strong><\/p>\n<ul>\n<li>Postgraduate Course &#8220;Clinical Development&#8221;<\/li>\n<\/ul>\n<p><strong>University of\u00a0Heidelberg, Institute for Pharmaceutical Sciences and Molecular Biotechnology <\/strong><\/p>\n<ul>\n<li>Lecture Series: &#8220;New drug research&#8221;<\/li>\n<\/ul>\n<hr \/>\n<h1><\/h1>\n<h1>2008 \u2013 2012 Novartis Pharma AG, Basel (CH)<\/h1>\n<p><strong>Site Head, Oncology Biomarker &amp; Clinical Imaging Basel<\/strong><\/p>\n<ul>\n<li>Established and led the Oncology Biomarker Group in Basel<\/li>\n<\/ul>\n<p><strong>Biomarker Program Leader<\/strong><\/p>\n<ul>\n<li>Developed project specific biomarker strategies for oncology development programs in early as well as full development phases within interdisciplinary matrix teams<\/li>\n<\/ul>\n<p><strong>Global Project Diagnostics Director, Novartis Molecular Diagnostics<\/strong><\/p>\n<ul>\n<li>Led an interdisciplinary, cross-sector matrix team to create a development plan and an economic analysis for the development of a molecular imaging agent as companion diagnostics<\/li>\n<\/ul>\n<hr \/>\n<h1><\/h1>\n<h1>2005 \u2013 2008 F. Hoffman-La Roche AG, Basel (CH)<\/h1>\n<p><strong>Biomarker Experimental Medicine Leader (Herceptin\u00ae)<\/strong><\/p>\n<ul>\n<li>Global responsibility for all biomarker &amp; companion diagnostics aspects of Herceptin\u00ae<\/li>\n<li>Market access strategy for HER2 molecular diagnostics<\/li>\n<li>Clinical strategy for HER2 molecular diagnostics for new indications<\/li>\n<li>Strategy for the identification of further potentially predictive biomarkers with the aim to further improve patient selection<\/li>\n<\/ul>\n<hr \/>\n<h1><\/h1>\n<h1>2003 \u2013 2004 Zeptosens AG, Witterswil (CH)<\/h1>\n<p><strong>Head of Marketing &amp; Sales Europe\u00a0<\/strong><\/p>\n<ul>\n<li>Prepared the market entry of a microarray based protein profiling system (e.g. for biomarker analyses in preclinical and clinical development)<\/li>\n<\/ul>\n<hr \/>\n<h1><\/h1>\n<h1>1999 \u2013 2003 GeneScan Europe AG \/ BioChip Technologies GmbH, Freiburg (D)<\/h1>\n<p><strong>Head of Strategic Marketing Diagnostics<\/strong><\/p>\n<ul>\n<li>Strategically aligned the portfolio<\/li>\n<\/ul>\n<p><strong>Project &amp; Product Management Pharmacogenetics<\/strong><\/p>\n<ul>\n<li>Launched a microarray based pharmacogenetic profiling system (CYP450 polymorphisms)<\/li>\n<li>Further development into an in-vitro diagnostic test<\/li>\n<\/ul>\n<p><strong>Product Management Molecular Diagnostics<\/strong><\/p>\n<ul>\n<li>Assessed conditions of the in-vitro diagnostics market<\/li>\n<\/ul>\n<hr \/>\n<h1><\/h1>\n<h1>Academic Education &amp; Activities<\/h1>\n<ul>\n<li>Studied pharmacy (University of Regensburg)<\/li>\n<li>PhD thesis in molecular biology (University of Heidelberg)<\/li>\n<li>Post Doctorate in molecular biology\/immunology (University of Freiburg)<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.mk-stracon.com\/?page_id=43\">Back to &gt;&gt; EXPERTISE<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>As of Sep. 2013: Lecturer\u00a0in Personalized Medicine Eidgen\u00f6ssische Technische Hochschule, Zurich Postgraduate Course &#8220;Clinical Development&#8221; University of\u00a0Heidelberg, Institute for Pharmaceutical Sciences and Molecular Biotechnology Lecture Series: &#8220;New drug research&#8221; 2008 \u2013 2012 Novartis Pharma AG, Basel (CH) Site Head, Oncology<span class=\"ellipsis\">&hellip;<\/span><\/p>\n<div class=\"read-more\"><a href=\"https:\/\/www.mk-stracon.com\/?page_id=52\">Read more &#8250;<\/a><\/div>\n<p><!-- end of .read-more --><\/p>\n","protected":false},"author":1,"featured_media":57,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=\/wp\/v2\/pages\/52"}],"collection":[{"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=52"}],"version-history":[{"count":22,"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=\/wp\/v2\/pages\/52\/revisions"}],"predecessor-version":[{"id":217,"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=\/wp\/v2\/pages\/52\/revisions\/217"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=\/wp\/v2\/media\/57"}],"wp:attachment":[{"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=52"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}